Alopecia: Clinical Trials

656 trials for Alopecia, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

306 completed, 117 unknown, 76 recruiting, 46 not yet recruiting. 235 Not applicable, 171 Phase 2, 77 Phase 3, 75 Phase 1, 37 Phase 4.

By phase and status

Phase	Trials	Status
Not applicable	235	Completed 107, Unknown 50, Recruiting 24, Active not recruiting 15, Not yet recruiting 13, Withdrawn 12, Terminated 10, Enrolling by invitation 4
Phase 2	171	Completed 87, Recruiting 20, Unknown 19, Not yet recruiting 13, Terminated 13, Withdrawn 10, Active not recruiting 8, Enrolling by invitation 1
Phase 3	77	Completed 39, Recruiting 13, Not yet recruiting 8, Active not recruiting 7, Unknown 6, Terminated 2, Withdrawn 2
Phase 1	75	Completed 32, Unknown 19, Recruiting 11, Terminated 5, Not yet recruiting 3, Active not recruiting 2, Withdrawn 2, Enrolling by invitation 1
Phase 4	37	Completed 13, Unknown 12, Not yet recruiting 6, Recruiting 2, Terminated 2, Withdrawn 2
Early Phase 1	19	Completed 10, Unknown 3, Not yet recruiting 2, Active not recruiting 1, Recruiting 1, Terminated 1, Withdrawn 1

Follow Alopecia: new trials by email Literature Review of Alopecia trials Research Report on Alopecia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia. Minoxidil oral solution, Placebo oral solution - Androgenetic Alopecia, Androgenetic Alopecia (AGA)	Phase 3	Not yet recruiting	Eurofarma Laboratorios S.A.	372	2027-01-31	2026-04-14
Clinical Study of DA-002 and DA-005 as a Treatment for Hair Loss DA-005, Topical minoxidil 5%, DA-002 - Androgenetic Alopecia, Female Pattern Baldness	Phase 3	Withdrawn	Applied Biology, Inc.		2027-01-15	2026-11-02
A Study on the Efficacy and Safety of Microneedling for Male Androgenetic Alopecia Minoxidil 5 %, Microneedling - Androgenetic Alopecia	Not applicable	Not yet recruiting	Cheng Zhou	190	2027-01-01	2026-08-11
Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of N1087 in Participants With Female Pattern Hair Loss (MINORA-WOMEN) N1087, Placebo - Female Pattern Hair Loss, Female Pattern Hair Loss, Androgenic Alopecia	Phase 3	Not yet recruiting	Eurofarma Laboratorios S.A.	372	2027-01-01	2026-01-09
Comparing Standard Platelet-Rich Plasma and Light-Enhanced Platelet-Rich Plasma for Treating Hair Loss in Androgenetic Alopecia: A Randomized Controlled Trial Platelet-Rich Plasma (PRP) Injections, Red-light photobiomodulation with cooling, Blue-light photobiomodulation - Androgenetic Alopecia	Early Phase 1	Not yet recruiting	Kimberly Meathrel	30	2026-12-30	2026-07-31
XVIE to Treat Androgenetic Alopecia (AGA) Decellularized allogeneic human amniotic fluid, Sodium chloride 0.9% injectable solution - Androgenetic Alopecia	Phase 1 / Phase 2	Not yet recruiting	Restore Biologics Holdings, Inc. dba Xtressé	30	2026-12-01	2026-08-12
Efficacy of Botulinum Toxin A Versus Nanofat in the Treatment of Androgenetic Alopecia: A Comparative Clinical Trial Botulinum Toxin Type A, Autologous Nanofat Injection - Androgenetic Alopecia	Phase 2 / Phase 3	Not yet recruiting	Sherief Ayman Hussein Shaamash	40	2026-12-01	2026-10-07
Phase 2 Efficacy and Safety of PP405 in Adult Females With Androgenetic Alopecia PP405 0.05% Topical Gel, Vehicle Topical Gel - Androgenetic Alopecia	Phase 2	Not yet recruiting	Pelage Pharmaceuticals, Inc.	200	2026-11-01	2026-10-30
Clinical Study to Evaluate the Impact of Nutraceutical Supplements in Participants With Self-Perceived Thinning Hair Nutraceuticals (Prototype) - Hair Thinning	Not applicable	Not yet recruiting	Unilever R&D	50	2026-10-08	2026-10-28
Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic Alopecia APSMNF 1, APSMNF 2, Eniagor® - Alopecia, Androgenetic	Phase 3	Not yet recruiting	Apsen Farmaceutica S.A.	336	2026-10-07	2026-09-08
Dietary Supplement for Telogen Effluvium Associated With GLP-1 Receptor Agonist Use Dietary Supplement for Hair Loss - Alopecia	Not applicable	Not yet recruiting	Farmoquimica S.A.	48	2026-10-01	2026-08-27
Oral Minoxidil With or Without a Multifactorial Drinkable Nutraceutical in Female Pattern Hair Loss: a Retrospective Study Oral low-dose Minoxidil, Drinkable multifactorial food supplement containing vitamins, minerals, plant extracts, and other bioactive compounds, formulated to support hair growth and scalp health in women. - Female Pattern Hair Loss, Female Pattern Hair Loss, Androgenic Alopecia		Not yet recruiting	Olistic Research Labs S.L.	30	2026-10-01	2026-10-07
Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic Alopecia Platelet-rich Plasma Left Side, Platelet-rich Plasma Right Side - Androgenic Alopecia	Early Phase 1	Not yet recruiting	Wake Forest University Health Sciences	16	2026-10-01	2026-08-04
Gut Microbiota and Trichoscopic Changes in Women With Telogen Effluvium on a Multifactorial Drinkable Nutraceutical: A Retrospective Observational Study Drinkable multifactorial food supplement containing vitamins, minerals, plant extracts, and other bioactive compounds, formulated to support hair growth and scalp health in women. - Gut Dysbiosis, Telogen Effluvium		Not yet recruiting	Olistic Research Labs S.L.	30	2026-10-01	2026-10-09
Comparison of Topical Calcipotriol and Intralesional Steroids in Alopecia Areata Calcipotriol, Triamcinolone Acetonide - Alopecia Areata	Phase 4	Not yet recruiting	Hayat Abad Medical Complex, Peshawar	60	2026-10-01	2026-09-21
The Role of Gut and Skin Microbiota in Alopecia Areata Fecal Microbial Transplant Enema, Placebo - Alopecia Areata, Fecal Microbiota Transplantation (FMT)	Not applicable	Not yet recruiting	Polyclinic GrandMed	30	2026-10-01	2026-07-15
Evidence-Based Integrated Protocol to Maximize Hair Follicle Survival in Follicular Unit Extraction (FUE) Integrated Evidence-Based FUE Protocol, Standard FUE Practice - Androgenetic Alopecia, Cicatricial Alopecia	Not applicable	Not yet recruiting	Assiut University	30	2026-10-01	2026-09-30
Efficacy and Safety of Two Hair Supplements in Men With Androgenic Alopecia formulation of green tea leaf extract, bamboo shoot extract and selenium-enriched yeast, formulation of grape seed extract, bamboo shoot extract and selenium-enriched yeast, Placebo (maltodextrin) - Androgenic Alopecia, Healthy Adult Male	Not applicable	Not yet recruiting	Activ'inside	99	2026-09-30	2026-09-08
Study to Evaluate Xtressé Gummy Supplement in Men With Androgenic Alopecia Xtressé Hair Growth Gummies, Placebo Comparator - Androgenic Alopecia, Hair Loss/Baldness	Not applicable	Enrolling by invitation	Restore Biologics Holdings, Inc. dba Xtressé	48	2026-09-23	2026-10-27
A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata VC005 tablets - Alopecia Areata	Phase 1	Recruiting	Jiangsu vcare pharmaceutical technology co., LTD	24	2026-09-22	2026-10-20

Alopecia: Clinical Trials

656 trials for Alopecia, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

By phase and status

Trials newest first · largest first

Narrower conditions

Broader conditions

Interventions

Sponsors

Countries

Top investigators

Results publications

NIH funding